Mikart, Inc. provides a range of services, including formulation development, clinical trial supplies, regulatory filing support, as well as clinical and commercial manufacturing, among others.
According to the company, ongoing investments in the business have included serialization-compliant packaging lines.
As part of the deal, Michael Kallelis will be joining the team at Mikart as the company’s new CEO.
Kallelis was most recently the vice president of business development at KMC Systems. He was also the chief operating officer and co-founder of the API contract manufacturing company Boston BioSystems, and has held senior roles at GE Life Sciences, Millipore, and Sepracor.
“In Nautic, Mikart has found the ideal partner to continue scaling the business while staying true to its customer-focused roots,” said Mikart’s retiring owner Miguel Arteche in a press release.
Kallelis added, “The work Miguel and Mikart’s management team have done to develop Mikart’s premier brand status in the market and strong reputation amongst customers is impressive. We hope to build off this foundation and partner with existing and future clients to fill their CDMO needs. ”
